ATE190497T1 - Verwendung des rekombinanten koloniestimulierenden faktors-1 - Google Patents

Verwendung des rekombinanten koloniestimulierenden faktors-1

Info

Publication number
ATE190497T1
ATE190497T1 AT91917632T AT91917632T ATE190497T1 AT E190497 T1 ATE190497 T1 AT E190497T1 AT 91917632 T AT91917632 T AT 91917632T AT 91917632 T AT91917632 T AT 91917632T AT E190497 T1 ATE190497 T1 AT E190497T1
Authority
AT
Austria
Prior art keywords
stimulating factor
csf
recombinant colony
recombinant
colony
Prior art date
Application number
AT91917632T
Other languages
English (en)
Inventor
Peter Ralph
Kong T Chong
James Devlin
Robert Zimmerman
Sharon Lea Aukerman
David B Ring
Sylvia Hsieh Ma
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE190497T1 publication Critical patent/ATE190497T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91917632T 1990-08-23 1991-08-23 Verwendung des rekombinanten koloniestimulierenden faktors-1 ATE190497T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57214990A 1990-08-23 1990-08-23
PCT/US1991/006052 WO1992003151A1 (en) 1990-08-23 1991-08-23 Uses of recombinant colony stimulating factor-1

Publications (1)

Publication Number Publication Date
ATE190497T1 true ATE190497T1 (de) 2000-04-15

Family

ID=24286555

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91917632T ATE190497T1 (de) 1990-08-23 1991-08-23 Verwendung des rekombinanten koloniestimulierenden faktors-1

Country Status (7)

Country Link
EP (2) EP0955056A1 (de)
JP (3) JP3501801B2 (de)
KR (1) KR100234870B1 (de)
AT (1) ATE190497T1 (de)
AU (1) AU646299B2 (de)
DE (1) DE69132051D1 (de)
WO (1) WO1992003151A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE222768T1 (de) * 1995-10-27 2002-09-15 Schering Corp Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
US6063372A (en) * 1995-10-27 2000-05-16 Inserm, Institut National De La Sante Et De La Recherche Medicale Uses of mammalian CTLA-8 and related reagents
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
RU2175554C2 (ru) * 1999-03-30 2001-11-10 Пермское научно-производственное объединение "Биомед" Оральный препарат интерферона в виде таблеток
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
RU2341296C2 (ru) 2002-05-24 2008-12-20 Энджиотек Интернэшнл Аг Композиции и способы покрытия медицинских имплантатов
JP2007524671A (ja) * 2004-01-21 2007-08-30 カイロン コーポレイション Ｍ−ｃｓｆムテインおよびその使用
GB0900786D0 (en) * 2009-01-19 2009-03-04 Natracine Uk Ltd Therapeutic compositions
WO2011071118A1 (ja) * 2009-12-09 2011-06-16 国立大学法人京都大学 ニトロビンを含む多能性幹細胞の心筋細胞への分化促進剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0643972B1 (de) * 1987-09-22 2002-03-06 Chiron Corporation Verwendung von rekombinantem koloniestimulierendem Faktor-1 zur Herstellung eines Medikaments gegen Cytomegalovirusinfektionen

Also Published As

Publication number Publication date
EP0549702B1 (de) 2000-03-15
JP2002275089A (ja) 2002-09-25
EP0549702A1 (de) 1993-07-07
JPH06500558A (ja) 1994-01-20
JP3501801B2 (ja) 2004-03-02
AU646299B2 (en) 1994-02-17
DE69132051D1 (de) 2000-04-20
EP0955056A1 (de) 1999-11-10
KR930701186A (ko) 1993-06-11
JP2003292454A (ja) 2003-10-15
WO1992003151A1 (en) 1992-03-05
AU8647491A (en) 1992-03-17
KR100234870B1 (ko) 1999-12-15

Similar Documents

Publication Publication Date Title
NO882772D0 (no) Nye former koloni-stimulerende faktor-1.
RU2008146718A (ru) Способы лечения неврологических состояний с применением гематопоэтических факторов роста
DK0741576T3 (da) Sam-administrering af interleukin-3 mutanter med kolonistimulerende faktorer
RU94022480A (ru) Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с
KR900700475A (ko) 항균제
DK0790255T3 (da) Monoklonale antistoffer som er rettet mod den cytotoksiske lymfocytmodningsfaktor
DK494681A (da) Femgangsmaade til fremstilling af interferoner
DE3856588D1 (de) Biologisch-aktive Bakterizide/permeabilitätserhöhende Proteinbruchstücke
ATE124959T1 (de) Herstellung und verwendung von nicht- glycosiliertem il-6.
DE69132051D1 (de) Verwendung des rekombinanten koloniestimulierenden faktors-1
ATE131493T1 (de) Polypeptide und polypeptidanaloge mit inhibitorischer aktivität gegenüber menschlicher elastase
DK471386D0 (da) Farmaceutisk komposition til behandling af leukopeni
DE69206301D1 (de) Protein mit der Aktivität vom Typ von Cytokin, dafür kodierende rekombinante DNS, transformierte Zellen und Mikroorganismen.
NO177863C (no) Fremgangsmåte for fremstilling av rekombinant humant IFN-type I, IFN1, IFN-pseudo-2, -3, og -4, samt ekspresjonsvektorer
ATE403726T1 (de) Cytokin-proteinfamilie
DK12990D0 (da) Human granulocyt-makrofag-kolonistimulerende faktor og muteiner heraf
CA2090121A1 (en) Uses of colony stimulating factor-1
ATE286509T1 (de) Interferon alpha/beta bindendes protein, seine herstellung und anwendung
DK103891A (da) Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon
ES8703928A1 (es) Un metodo para preparar la proteina factor de estimulacion de colonias (csf-1)recombinante
DK130292D0 (da) Rekombinant fremstillet, draebt adjuveret vaccine til brug i mink til profylakse mod parvovirus infektionen mink enteritis